Shares of Albemarle Co. (NYSE:ALB – Get Free Report) have received an average rating of “Hold” from the twenty ratings firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $175.05.
ALB has been the subject of a number of research reports. KeyCorp dropped their price target on Albemarle from $178.00 to $159.00 and set an “overweight” rating for the company in a research note on Thursday, March 7th. Wolfe Research initiated coverage on Albemarle in a report on Friday, March 1st. They issued a “peer perform” rating for the company. UBS Group decreased their price objective on Albemarle from $137.00 to $125.00 and set a “neutral” rating for the company in a report on Thursday, February 15th. Vertical Research downgraded Albemarle from a “buy” rating to a “hold” rating and set a $145.00 price objective for the company. in a report on Friday, March 8th. Finally, TD Cowen downgraded Albemarle from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $220.00 to $130.00 in a report on Monday, January 29th.
Read Our Latest Analysis on ALB
Hedge Funds Weigh In On Albemarle
Albemarle Stock Up 0.3 %
Shares of ALB opened at $112.15 on Friday. Albemarle has a 52 week low of $106.69 and a 52 week high of $247.44. The stock has a market capitalization of $13.18 billion, a price-to-earnings ratio of 8.41, a PEG ratio of 2.27 and a beta of 1.62. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.86 and a current ratio of 1.47. The stock has a fifty day moving average of $123.05 and a 200-day moving average of $129.07.
Albemarle (NYSE:ALB – Get Free Report) last announced its quarterly earnings results on Thursday, February 15th. The specialty chemicals company reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.86. Albemarle had a return on equity of 26.62% and a net margin of 16.36%. The company had revenue of $2.36 billion during the quarter, compared to analysts’ expectations of $2.18 billion. During the same period in the prior year, the company earned $8.62 EPS. Albemarle’s revenue was down 10.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Albemarle will post 3.09 earnings per share for the current fiscal year.
Albemarle Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 15th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $1.60 annualized dividend and a dividend yield of 1.43%. Albemarle’s dividend payout ratio is presently 11.99%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 4/15 – 4/19
- Health Care Stocks Explained: Why You Might Want to Invest
- Comprehensive Analysis of PayPal Stock
- What is a Low P/E Ratio and What Does it Tell Investors?
- Intuitive Surgical Stock Can Trend Much Higher This Year
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.